FMC CORP (FMC) 120.97 +1.72 (+1.44%)
120.97 +1.72 (+1.44%)
US3024913036 - Common Stock - After market: 120.97 0 (0%)
Fundamental Rating
Taking everything into account, FMC scores 4 out of 10 in our fundamental rating. FMC was compared to 121 industry peers in the Chemicals industry. FMC has a medium profitability rating, but doesn't score so well on its financial health evaluation. FMC is quite expensive at the moment. It does show a decent growth rate.
Profitability
Profitability Rating
FMC has a Profit Margin of 12.67%. This is better than the industry average of 8.83%.
FMC has a Return On Assets of 6.58%. This is comparable to the industry average of 7.72%.
FMC's Return On Equity of 21.76% is in line with the rest of the industry. The industry average Return On Equity is 19.27%.
FMC has a Piotroski-F score of 5.00. This indicates an average health and profitability for FMC.
VS Industry
ROA (6.58%) VS Industry: 43% outperformed.
0.23
624.60
ROE (21.76%) VS Industry: 58% outperformed.
0.26
237.19
Profit Margin (12.67%) VS Industry: 64% outperformed.
0.51
45.08
Valuation
Valuation Rating
With a Price/Earnings Ratio of 16.33, FMC is valued correctly.
With a Forward Price/Earnings Ratio of 15.27, FMC is valued correctly.
When comparing the current price to the book value of FMC, we can conclude it is valued correctly. It is trading at 4.48 times its book value.
Compared to an average industry Price/Earning Ratio of 12.03, FMC is valued slightly more expensive.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
Compared to an average industry price book ratio of 1.90, FMC is valued more expensive than its industry peers. 85% of the companies listed in the same industry are valued cheaper.
When comparing the Enterprise Value to EBITDA ratio of FMC to the average industry ratio of 9.27, FMC is valued more expensive than its industry peers.
VS Industry
Price/Earnings (16.33) VS Industry: 30% outperformed.
177.68
2.00
Price/Book (4.48) VS Industry: 15% outperformed.
764.36
0.02
Enterprise Value/ EBITDA (12.58) VS Industry: 30% outperformed.
13,692.96
0.15
Growth
Growth Rating
FMC shows a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 22.28% yearly.
The Revenue has grown by 15.01% in the past year. This is quite good.
Measured over the past 5 years, FMC shows a quite strong growth in Revenue. The Revenue has been growing by 15.05% on average per year.
The Earnings Per Share has been growing slightly by 6.93% over the past year.
FMC is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 8.48% yearly.
The Revenue is expected to grow by 2.90% on average over the next 5 years.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | 22.28% | 6.82% | 6.93% | 6.93% | 10.13% | 10.74% | 8.48% |
| Revenue | 15.05% | 7.97% | 15.01% | 7.81% | 6.32% | 5.37% | 2.9% |
Health
Health Rating
A Current Ratio of 1.43 indicates that FMC should not have too much problems paying its short term obligations.
An Altman-Z score of 2.89 indicates that FMC is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score is in line with the industry averages, which is at 2.52.
FMC has a Piotroski-F score of 5.00. This indicates an average health and profitability for FMC.
Compared to an average industry Current Ratio of 2.02, FMC is worse placed to pay its short term obligations than its industry peers.
FMC has a Quick Ratio of 1.43. This is a bad value and indicates that FMC is not financially healthy enough and could expect problems in meeting its short term obligations.
When comparing the Quick Ratio of FMC to the average industry Current Ratio of 1.32, FMC is less able to pay its short term obligations than its industry peers.
Compared to an average industry Debt to Equity Ratio of 0.58, FMC is more dependent on financing than its industry peers.
VS Industry
Debt/Equity (0.81) VS Industry: 35% outperformed.
53.61
0.00
Quick Ratio (1) VS Industry: 33% outperformed.
0.01
65.94
Current Ratio (1.43) VS Industry: 26% outperformed.
0.01
65.94
Altman-Z (2.89) VS Industry: 57% outperformed.
-529.46
142.65
Dividend
Dividend Rating
The dividend of FMC is nicely growing with an annual growth rate of 9.83%!
36.40% of the earnings are spent on dividend by FMC. This is a low number and sustainable payout ratio.
FMC has paid a dividend for at least 10 years, which is a reliable track record.
FMC has a Yearly Dividend Yield of 2.00%.
FMC's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
Compared to an average industry Dividend Yield of 2.26, FMC is paying slightly less dividend.
Compared to the average S&P500 Dividend Yield of 2.60, FMC is paying slightly less dividend.
VS Industry
Dividend Yield (2%) VS Industry: 40% outperformed.
0.30
22.94
FMC CORP120.97
NYSE:FMC (3/29/2023, 7:06:56 PM)+1.72 (+1.44%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-07 2023-02-07/amc
Earnings (Next)05-01 2023-05-01/amc
Inst Owners90.69%
Inst Owner Change-0.3%
Ins Owners0.54%
Ins Owner Change7.53%
Market Cap15.13B
Analysts76.67
Price Target147.18 (21.67%)
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2% |
Dividend Growth(5Y)9.83%
DP36.4%
Div Incr Years5
Div Non Decr Years10
Ex-Date03-30 2023-03-30 (0.58)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.8%
Min EPS beat(2)0.81%
Max EPS beat(2)8.79%
EPS beat(4)4
Avg EPS beat(4)5.01%
Min EPS beat(4)0.81%
Max EPS beat(4)9.04%
Revenue beat(2)2
Avg Revenue beat(2)3.36%
Min Revenue beat(2)1.94%
Max Revenue beat(2)4.78%
Revenue beat(4)4
Avg Revenue beat(4)4.65%
Min Revenue beat(4)1.94%
Max Revenue beat(4)7.9%
PT rev (1m)1.11%
PT rev (3m)4.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.67%
EPS NY rev (1m)-5.91%
EPS NY rev (3m)-5.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.41%
Revenue NY rev (1m)2.24%
Revenue NY rev (3m)2.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.33 | ||
| Fwd PE | 15.27 | ||
| P/S | 2.61 | ||
| P/FCF | 34.39 | ||
| P/OCF | 25.99 | ||
| P/B | 4.48 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.58 |
EPS(TTM)7.41
EY6.13%
EPS(NY)7.92
Fwd EY6.55%
FCF(TTM)3.52
FCFY2.91%
OCF(TTM)4.66
OCFY3.85%
SpS46.38
BVpS27
TBVpS-6.81
PEG (NY)2.36
PEG (5Y)0.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.58% | ||
| ROE | 21.76% | ||
| ROIC | 13.36% | ||
| ROICexc | 14.42% | ||
| ROICexgc | 34.6% | ||
| OM | 20.6% | ||
| PM | 12.67% | ||
| GM | 40.1% |
ROICexgc(3y)32.63%
ROICexcg growth 3Y5.54%
ROICexcg growth 5Y20.31%
ROICexc(3y)13.75%
ROICexc growth 3Y6.02%
ROICexc growth 5Y19.17%
OM growth 3Y-0.42%
OM growth 5Y4.91%
PM growth 3Y7.05%
PM growth 5Y-7.41%
GM growth 3Y-3.91%
GM growth 5Y0.95%
F-Score5
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 7.44 | ||
| Debt/EBITDA | 2.4 | ||
| Cap/Depr | 84% | ||
| Profit Quality | 59.89% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.89 |
F-Score5
WACC9.06%
ROIC/WACC3.82
Cap/Depr(3y)86.88%
Cap/Depr(5y)95.42%
Profit Quality(3y)80.4%
Profit Quality(5y)69.34%
Growth
EPS 1Y6.93%
EPS 3Y6.82%
EPS 5Y22.28%
EPS growth Q2Q9.72%
EPS Next Y6.93%
EPS Next 2Y10.13%
EPS Next 3Y10.74%
EPS Next 5Y8.48%
Revenue growth 1Y15.01%
Revenue growth 3Y7.97%
Revenue growth 5Y15.05%
Revenue growth Q2Q14.74%
Revenue Next Year7.81%
Revenue Next 2Y6.32%
Revenue Next 3Y5.37%
Revenue Next 5Y2.9%
EBIT growth 1Y10%
EBIT growth 3Y7.51%
EBIT growth 5Y20.69%
EBIT Next Year24.08%
EBIT Next 3Y12.89%
EBIT Next 5Y9.3%
FCF growth 1Y-37.78%
FCF growth 3Y8.29%
FCF growth 5Y11.99%
OCF growth 1Y-28.98%
OCF growth 3Y6.04%
OCF growth 5Y11.66%
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA